Remove 2024 Remove Biopharma Remove Pharma Remove Prescription
article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. In classic Amazon style, its pharmacy offers two-day shipping on prescriptions by mail, with same-day delivery available in seven markets, with plans to add a dozen more cities by year end.

Retail 52
article thumbnail

Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts

Clarivate

This blog summarizes a portion of the data collected, which was previously shared in a poster presented at the May 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference (Read the poster ). Nearly early 1 in 5 expect to withdraw some Medicare Advantage plans from the market due to the law (see figure 4).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UnitedHealth-Walmart partnership heats up U.S. Medicare provider competition

Clarivate

Insurers that incentivize using Walmart facilities in Medicare Advantage and prescription drug plans (PDPs) have seen success; Humana has a long-running standalone Part D plan with Walmart pharmacies as preferred network locations.

article thumbnail

Beyond transparent pricing: decoding the strategies of major PBMs

Clarivate

The three largest pharmacy benefit managers (PBMs) in the United States—Express Scripts, OptumRx and CVS Caremark—control more than 80% of the market share (per Clarivate data, as of January 2024). Click here to learn more about how Clarivate helps biopharma companies navigate market access across global markets.

Retail 59
article thumbnail

The U.S. health insurance market is undergoing a post-pandemic sea change

Clarivate

According to Clarivate’s latest enrollment data, as of January 2024, Medicaid enrollment had plummeted by nearly 9 million compared to six months prior. For 2024, 18% of enrollees were new to exchange coverage, according to the Centers for Medicare and Medicaid Services. million between January 2023 and January 2024. to about 2.5

article thumbnail

Think Tank: Mastering Metrics

PM360

Christoph Bug Vice President of Global Medical Veeva christoph.bug@veeva.com Functional silos can create tunnel vision and cause misalignment of strategy, objectives, and transparency of interactions with biopharmas and their customers like HCPs. To best align success measures and unify systems (and people) start with the end goal in mind.

Media 52
article thumbnail

CMS enters drug price negotiation arena in sea change for industry

Clarivate

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.